跳至主要内容
临床试验/ISRCTN10232550
ISRCTN10232550已完成未知

Intramuscular oxytocics: a multi-centre randomised comparison study of intramuscular carbetocin, syntocinon and syntometrine for the third stage of labour following vaginal birth

orth Bristol NHS Trust0 个研究点目标入组 5,717 人开始时间: 2018年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5,717

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 27/06/2018:
  • 1. =18 years of age at time of delivery
  • 2. Vaginal birth
  • 3. Live, singleton pregnancy
  • 4. >24 weeks gestation
  • Previous inclusion criteria:
  • 1. =18 years of age at time of baby’s birth
  • 2. Planning to have a vaginal birth (spontaneous and instrumental)
  • 3. Singleton pregnancy
  • 4. Any gestational age

排除标准

  • Current exclusion criteria as of 27/06/2018:
  • 1. Significant antepartum haemorrhage (>50ml) or suspected or proven placenta abruption
  • 2. Maternal coagulation disorder
  • 3. Women who would decline blood products if required
  • 4. Known or suspected hypertensive disorders
  • 5. Peripheral, hepatic or cardiac disease
  • 6. Epilepsy
  • 7. Patients with an allergy or hypersensitivity to any of the active ingredients of the study drugs
  • Previous exclusion criteria:
  • 1. Significant antepartum haemorrhage (>50ml) or suspected or proven placenta abruption
  • 2. Maternal coagulation disorder
  • 3. Multiple pregnancy (twins or higher order)
  • 4. Intrauterine fetal death
  • 5. Patients who would decline blood products if required (i.e., Jehovah's Witnesses - clinicians may have a lower threshold for administering additional prophylactic uterotonic drugs to these patients)
  • 6. Known or suspected hypertensive disorders, including pre-eclampsia,
  • pregnancy induced hypertension, essential hypertension (even if blood pressure well controlled), and patients with hypertension in labour
  • 7. Patients with peripheral, hepatic or cardiac disease
  • 8. Patients with an allergy or hypersensitivity to any of the active ingredients in Carbetocin, Syntometrine or Syntocinon

研究者

发起方
orth Bristol NHS Trust

相似试验